141 related articles for article (PubMed ID: 12579282)
1. Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
Higuchi Y; Asaumi J; Murakami J; Matsuzaki H; Wakasa T; Inoue T; Konoucni H; Hisatomi M; Yanagi Y; Honda Y; Shigehara H; Kishi K
Oncol Rep; 2003; 10(2):415-20. PubMed ID: 12579282
[TBL] [Abstract][Full Text] [Related]
2. Effects of p53 gene therapy in radiotherapy or thermotherapy of human head and neck squamous cell carcinoma cell lines.
Higuchi Y; Asaumi J; Murakami J; Matsuzaki H; Wakasa T; Inoue T; Shigehara H; Konouchi H; Hisatomi M; Kawasaki S; Hiraki Y; Kishi K
Oncol Rep; 2003; 10(3):671-7. PubMed ID: 12684642
[TBL] [Abstract][Full Text] [Related]
3. Thermoradiotherapy combined with p53 gene therapy of human salivary gland adenocarcinoma cell line.
Asaumi J; Higuchi Y; Murakami J; Matsuzaki H; Wakasa T; Inoue T; Shigehara H; Konouchi H; Hisatomi M; Kawasaki S; Kuroda M; Hiraki Y; Kishi K
Oncol Rep; 2003; 10(1):71-4. PubMed ID: 12469147
[TBL] [Abstract][Full Text] [Related]
4. Thermoradiotherapy in human head and neck squamous cell carcinoma cell lines.
Asaumi J; Higuchi Y; Murakami J; Kuroda M; Shibuya K; Konouchi H; Hisatomi M; Matsuzaki H; Shigehara H; Kawasaki S; Kishi K; Hiraki Y
Int J Mol Med; 2002 Sep; 10(3):287-91. PubMed ID: 12165802
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
Higuchi Y; Asaumi J; Murakami J; Wakasa T; Inoue T; Kuroda M; Shibuya K; Shigehara H; Kawasaki S; Fukui K; Kishi K; Hiraki Y
Oncol Rep; 2002; 9(6):1233-6. PubMed ID: 12375026
[TBL] [Abstract][Full Text] [Related]
6. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Zhu GY; Xu B
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
[TBL] [Abstract][Full Text] [Related]
7. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
Clayman GL; el-Naggar AK; Roth JA; Zhang WW; Goepfert H; Taylor DL; Liu TJ
Cancer Res; 1995 Jan; 55(1):1-6. PubMed ID: 7805018
[TBL] [Abstract][Full Text] [Related]
8. Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.
Frank DK; Frederick MJ; Liu TJ; Clayman GL
Clin Cancer Res; 1998 Oct; 4(10):2521-8. PubMed ID: 9796986
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of head and neck squamous cell carcinoma by recombinant adenovirus-p53 combined with radiotherapy: a phase II clinical trial of 42 cases].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Cai Y; Zhu GY; Xu B; Lü YY
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2023-8. PubMed ID: 14703408
[TBL] [Abstract][Full Text] [Related]
10. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy.
Pirollo KF; Hao Z; Rait A; Jang YJ; Fee WE; Ryan P; Chiang Y; Chang EH
Oncogene; 1997 Apr; 14(14):1735-46. PubMed ID: 9135075
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
Edelman J; Edelman J; Nemunaitis J
Curr Opin Mol Ther; 2003 Dec; 5(6):611-7. PubMed ID: 14755887
[TBL] [Abstract][Full Text] [Related]
12. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
Liu TJ; Zhang WW; Taylor DL; Roth JA; Goepfert H; Clayman GL
Cancer Res; 1994 Jul; 54(14):3662-7. PubMed ID: 8033080
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: an in vivo and in vitro study.
Lalonde ES; Beyer G; Friedlander PL; Kolls JK
Head Neck; 2002 Dec; 24(12):1038-46. PubMed ID: 12454941
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model.
Eicher SA; Clayman GL; Liu TJ; Shillitoe EJ; Storthz KA; Roth JA; Lotan R
Clin Cancer Res; 1996 Oct; 2(10):1659-64. PubMed ID: 9816113
[TBL] [Abstract][Full Text] [Related]
15. FasL gene therapy: a new therapeutic modality for head and neck cancer.
ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS
Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers.
Clayman GL; Frank DK; Bruso PA; Goepfert H
Clin Cancer Res; 1999 Jul; 5(7):1715-22. PubMed ID: 10430074
[TBL] [Abstract][Full Text] [Related]
17. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
Kim SH; Wong RJ; Kooby DA; Carew JF; Adusumilli PS; Patel SG; Shah JP; Fong Y
Eur J Cancer; 2005 Jan; 41(2):313-22. PubMed ID: 15661558
[TBL] [Abstract][Full Text] [Related]
18. The current status of gene therapy.
Clayman GL
Semin Oncol; 2000 Aug; 27(4 Suppl 8):39-43. PubMed ID: 10952437
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
20. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
